Table 1.
2000-2001 (n = 213) | 2002-2003 (n = 224) | 2004-2005 (n = 207) | 2006-2007 (n = 145) | 2008-2009 (n = 147) | P value for trend† | All years (n = 936) | |
---|---|---|---|---|---|---|---|
Males, % | 75 | 71 | 81 | 81 | 76 | 0.21 | 77 |
Age, median years (IQR) | 37 (30–45) | 38 (30–45) | 39 (31–46) | 36 (28–46) | 36 (28–46) | 0.50 | 38 (30–46) |
Race/ethnicity, % | |||||||
Non-Hispanic white | 44 | 39 | 47 | 48 | 36 | 0.67 | 43 |
Non-Hispanic black | 37 | 44 | 36 | 34 | 44 | 0.83 | 39 |
Hispanic | 15 | 13 | 14 | 14 | 18 | 0.59 | 15 |
Other or unknown | 4 | 3 | 3 | 4 | 3 | 0.65 | 3 |
HIV infection risk group, % | |||||||
Men who have sex with men (MSM) | 50 | 48 | 57 | 69 | 49 | 0.08 | 54 |
High-risk heterosexual | 39 | 41 | 32 | 21 | 44 | 0.26 | 36 |
Injection drug use (IDU, including MSM IDU) | 6 | 6 | 6 | 3 | 1 | 0.02 | 5 |
Other or unknown | 5 | 6 | 5 | 6 | 7 | 0.54 | 6 |
Medical insurer, % | |||||||
Privately insured | 57 | 67 | 67 | 70 | 58 | 0.51 | 64 |
Publically insured | 34 | 29 | 29 | 24 | 33 | 0.37 | 30 |
Other or unknown | 9 | 4 | 3 | 6 | 10 | 0.70 | 6 |
Type of facility, % | |||||||
Public | 28 | 46 | 42 | 28 | 49 | 0.03 | 39 |
Private | 72 | 54 | 58 | 72 | 51 | 0.03 | 61 |
*For inclusion in this analysis, patients must have had a CD4 cell count measured within 1 month prior to or up to 3 months after the date of HIV diagnosis while remaining antiretroviral-naïve.
†By Cochran-Armitage test for proportions (%), and by Jonckheere-Terpstra nonparametric test for continuous variables.